CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting

Mortality Clinical Trial

— CASUS  

Official title:

The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05026437
• Other study ID #: SU2019
• Status: Completed
• Start date: January 2, 2019
• Est. completion date: April 10, 2019

Study information

• Verified date: August 2021
• Source: Antalya Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Description:

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 204
• Est. completion date: April 10, 2019
• Est. primary completion date: March 10, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Undergoing coronary artery bypass grafting

• Over 18 years of age

• Staying at least 24 hours in the cardiac intensive care unit

Exclusion Criteria:

• Emergency surgery

Related Conditions & MeSH terms

• Coronary Artery Bypass Grafting
• Mortality

Intervention

Other:
• Cardiac surgery score and APACHE II scoring
Cardiac surgery score and APACHE II will calculated on the first postoperative day.

Locations

Country	Name	City	State
Turkey	Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital	Istanbul
Turkey	Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey	Istanbul

Sponsors (3)

Lead Sponsor	Collaborator
Antalya Training and Research Hospital	Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Haydarpasa Numune Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality at 7 days	Mortality in the first 7 days after surgery	7 days
Primary	Mortality at 30 days	Mortality in the first 30 days after surgery	30 days
Secondary	Length of stay in the cardiac intensive care unit	Only the length of the initial stay in the cardiac intensive care unit up to 3 months	Up to 3 months (Through study completion)
Secondary	Length of the stay in the hospital	It includes the period from surgery to discharge	Up to 3 months (Through study completion)